CD8A and neoplasm: We also found that in vivo daily treatment with LDHi versus vehicle increased the proliferative capacity of CD8+ and CD4+ Teff TILs while reducing tumor cell proliferation, as assessed by Ki67 expression (Figure 4, F and G).